Nanomedicines as Therapeutics in HIV-AIDS

E-ISSN： 2211-7393|4|4|255-266

ISSN： 2211-7385

Source： Pharmaceutical Nanotechnology, Vol.4, Iss.4, 2016-12, pp. : 255-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411

By Uglietti Alessia Maserati Renato

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 559-565

Informa Healthcare

Access to resources Recommend Favorite

Etravirine for the treatment of HIV/AIDS

By Schrijvers Rik

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1087-1096

Informa Healthcare

Access to resources Recommend Favorite

Nanomedicines as Cancer Therapeutics: Current Status

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 362-378

Bentham Science Publishers

Access to resources Recommend Favorite

Access to HIV/AIDS drugs widens

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Funding boost for HIV/AIDS initiatives

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite